SPO Global Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPOM research report →
Companywww.gerpanghealthcare.com
Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.
- CEO
- Fengyou Lu
- IPO
- 1999
- Employees
- 7
- HQ
- Jinan, CN
Price Chart
Valuation
- Market Cap
- $69.29K
- P/E
- -1.05
- P/S
- 0.05
- P/B
- -3.96
- EV/EBITDA
- -1.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.07%
- Op Margin
- -20.64%
- Net Margin
- -32.55%
- ROE
- 260.31%
- ROIC
- -183.34%
Growth & Income
- Revenue
- $243.36K · -78.66%
- Net Income
- $-185,795 · 97.28%
- EPS
- $0.00 · 102.17%
- Op Income
- $-9,839
- FCF YoY
- -98.59%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.66
- Avg Volume
- 2.02M
Get TickerSpark's AI analysis on SPOM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SPOM Coverage
We haven't published any research on SPOM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SPOM Report →